Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients

Bilun Gemicioglu (Istanbul, Turkey), Bilun Gemicioglu, Sule Gundogdu, Buket Caliskaner Ozturk, Fatma Eren

Source: International Congress 2016 – Functional assessment of the airways
Session: Functional assessment of the airways
Session type: Thematic Poster
Number: 4139
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bilun Gemicioglu (Istanbul, Turkey), Bilun Gemicioglu, Sule Gundogdu, Buket Caliskaner Ozturk, Fatma Eren. Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 4139

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Lung function change and exacerbations in patients with COPD in the WISDOM study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Evaluation of airway sGaw in Japanese COPD patients treated with triple therapy using salmeterol/fluticasone propionate 50/250 and tiotropium bromide
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008



First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Effects of ciclesonide on the management of stable COPD with airway eosinophilia
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Can emphysema predict exacerbations and changes in PFTs in COPD?
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Neutrophils and spirometry changes in COPD patients treated with roflumilast
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD
Source: Annual Congress 2007 - New drugs for COPD
Year: 2007



Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013